Cercare Medical Neurosuite— 510(k) K202793

Substantially Equivalent

Cercare Medical Aps

FDA 510(k) clearance K202793 for Cercare Medical Neurosuite, Substantially Equivalent on 2021-05-17. Applicant: Cercare Medical Aps.

Clearance details

Applicant: Cercare Medical Aps
Product code: Code LLZ
Advisory panel: Radiology
Date received: 2020-09-22
Decision date: 2021-05-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Aarhus, DK

Download summary PDF View on FDA.gov ↗

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.